Search clinical trials for: tumor burden

Total 33438 results

Institut Curie

Unknown

Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer

Breast Cancer | Metastatic Cancer

France
Technische Universität Dresden
Advanced Biochemical Compounds GmbH

Terminated

F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response

Brain Tumor

Germany
Antisoma Research

Completed

Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma

Metastatic Renal Cell Carcinoma | Metastatic Malignant Melanoma

United Kingdom, New Zealand
Yale University
National Cancer Institute (NCI)

Completed

Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Children's Hospital Medical Center, Cincinnati
University of Cincinnati

Completed

I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma

Neuroblastoma | Pheochromocytoma
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Diagnosis of Rectal Cancer by Electromagnetic Device

Rectal Cancer

Italy
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating MAC-321 in Colorectal Cancer

Colorectal Neoplasms | Rectal Neoplasms | Colonic Neoplasms
Boehringer Ingelheim

Completed

Phase I of BIBW 2992/BIBF 1120 Combination Therapy in Solid Tumors

Neoplasms

United States
Yonsei University

Unknown

Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan

Colorectal Cancer

Korea, Republic of
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating EKB-569 in Advanced Colorectal Cancer

Colorectal Neoplasms | Rectal Neoplasms | Colonic Neoplasms
Göteborg University
Medical Research Council; Swedish Cancer Foundation

Completed

Insulin Treatment in Cancer Cachexia

Cancer Cachexia

Sweden
University of Virginia
National Cancer Institute (NCI)

Unknown

Modafinil in Treating Fatigue in Patients With Cancer

Depression | Fatigue | Unspecified Adult Solid Tumor, Protocol Specific | Cognitive/Functional Effects

United States
University Hospital Tuebingen

Completed

Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery

Epilepsy | Primary Brain Tumor

Germany
AstraZeneca

Completed

Open Label, Dose Escalation Phase I Study of AZD2281

Advanced Solid Malignancies

Japan
Soonchunhyang University Hospital

Unknown

Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer

Gastric Cancer | Elderly | Oxaliplatin | S-1 | First-Line
University of Milan

Completed

Communicating Veins Between Adjacent Hepatic Veins: an Intra-operative Ultrasound Study

Liver Tumors

Italy
St. Luke's-Roosevelt Hospital Center
Sanofi

Completed

Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas

Pancreatic Neoplasms

United States
GAAD Medical Research Institute Inc.

Unknown

Far Infrared Radiation Treatment for Prostate Cancer

Prostatic Neoplasms

Canada
GAAD Medical Research Institute Inc.

Unknown

A Study to Evaluate the Effect of Far Infrared Radiation for Cancer Treatment

Neoplasms

Canada
Pfizer

Completed

Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction

Chemotherapy | Liver Dysfunction | Unspecified Adult Solid Tumor | Neoplasms, Solid Tumor

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancer

Gastric Cancer

Japan
Arno Therapeutics
University of Kentucky; Arch Medical Services Inc., DBA The Center for Cancer...

Completed

Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies

Tumors

United States
Cylene Pharmaceuticals

Terminated

Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas

Lymphoma | Advanced Solid Tumors

United States
Cylene Pharmaceuticals

Completed

Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas

Lymphoma | Advanced Solid Tumors

United States
Massachusetts General Hospital
Sanofi; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Genentech...

Terminated

Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer

Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma

Malignant Brain Tumor | Brain Stem Glioma,

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Clinical Studies of Gemcitabine-Oxaliplatin

Osteosarcoma | Medulloblastoma | Neuroblastoma | Central Nervous System Tumors

France
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Etanercept in Moderate to Severe Asthma

Asthma

United States
Taiho Oncology, Inc.

Completed

Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer

Gastric Cancer

United States
Centre Hospitalier Universitaire Vaudois

Unknown

Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery

Colorectal Cancer | Metastatic Cancer

Switzerland
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents

Malignant Tumors | Refractory Tumors

France
University of Turin, Italy

Completed

5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors

Neuroendocrine Tumors

Italy
Komagome Hospital

Unknown

Bone Marrow-derived Cells' Contribution to Tumor Formation and Inflammation

Gastrointestinal Neoplasms

Japan
AstraZeneca

Completed

IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma

Neoplasms, Squamous Cell

United States, Czech Republic, Poland, Germany, Belgium, Taiwan, India, Serbia
Gruppo Oncologico Italiano di Ricerca Clinica

Unknown

Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC

Advanced Non-Small Cell Lung Cancer

Italy
Centre Oscar Lambret

Unknown

Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer

Sarcoma | Cervical Cancer | Ovarian Cancer | Fallopian Tube Cancer | Vulvar Cancer | Endometrial Cancer | Vaginal Cancer

France
Immunicon

Unknown

Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemotherapy (IMMC-38)

Prostate Cancer | Hormone Refractory Prostate Cancer

United States
Novacea

Completed

A New Formulation of Calcitriol (DN-101) in Patients With Advanced Malignancies

Neoplasms

United States
Nantes University Hospital

Completed

Colonoscopy by Videocapsuls Versus Standard Colonoscopy. Intra-individual Comparison for the Subject With a Medium or High Risk of Colorectal Cancer.

Colorectal Cancer

France
University of Regensburg
Essex Pharma Germany

Completed

Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma

Glioblastoma

Germany
Kochi University

Unknown

Benefit of Roux-en-Y (R-Y) Reconstruction After Pancreaticoduodenectomy

Pancreatic Cancer

Japan
Torrent Pharmaceuticals Limited

Completed

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fasted, Healthy, Adult Subjects

Healthy

United States
Torrent Pharmaceuticals Limited

Completed

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects

Healthy

United States
AstraZeneca

Completed

A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients

Carcinoma | Cancer | Tumors

Japan
TransMolecular

Unknown

A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma

Astrocytoma | Glioblastoma Multiforme | Malignant Glioma | GBM | Oligodendroglioma

United States
TransMolecular

Unknown

Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma

Astrocytoma | Glioblastoma Multiforme | Malignant Glioma | GBM | Oligodendroglioma

United States
Biogen

Completed

Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors

Lymphoma | Tumors

United Kingdom, United States
Millennium Pharmaceuticals, Inc.

Withdrawn

Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens

Ovarian Cancer

Italy, Switzerland
Memorial Sloan Kettering Cancer Center

Completed

Quality of Life Among Long-Term Survivors of Resected Gastric Cancer

Gastric Cancer

United States
Amgen

Completed

Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors

Solid Tumors | Oncology | Tumors

Search clinical trials for: tumor burden

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations